JLM-BioCity Pharma And Biotech Pitch Event (Photo Essay)

By BJLIfe/Sharon Altshul
Posted on 01/07/23

JLM-BioCity organized an event at the Azrieli Engineering College in Jerusalem, Israel on January 4, 2023. 

The evening was for both Biomed and Pharma Startups pitching to a panel of four leading investors:

• Dr Yael Gruenbaum-Cohen, Venture Partner, aMoon
• Ori Choshen, CEO, VLX Ventures
• Dr. Goozy Hartog, Principal, Pontifax
• Marc Feiglin, Head of Innovative Technologies, Deerfield Management

DEBBIE SHALEV Associate Professor of Chemistry, Department of Pharmaceutical Engineering hosted and moderated the evening.

The networking both before and after the formal presentations and investor panel showed the interest and excitement of participants to be back at a live event.

The startups who presented were:

1. Cavos Biotech High-resolution drug targets for cancer
   [https://www.linkedin.com/company/cavos-biotech-ltd/about](Cavos Biotech)
2. Concentor BioPharma Drugs for Type 2 Diabetes
   https://www.concenterbiopharma.com/
3. ITAY& Biond Drug for Autism http://itayandbiond.com
4. Limobrain Drug Delivery System to the Brain
5. Tzofen Oncological Gene Engineering Viruses against Cancer.
   www.Tzofen-bt.com
6. Vitalunga Anti Aging Drug https://www.linkedin.com/company/vitalunga/

JLM-BioCity is a non-profit organization, with over 1700 members, focused on developing Jerusalem’s bio-community. Serving as President is Joseph van Zwaren who has over 30 years of experience matching scientists and entrepreneurs to industry and investment.  CEO Dr. Hamutal Shahar has vast experience with scientific and operational management of worldwide clinical trials. Their team of dedicated volunteer staff members strives to assist the growth of the BioTechnology in Jerusalem.